Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
Radiotherapy is one of the pillars of modern cancer therapy. However, side effects associated with normal tissue toxicity limit the effectiveness of this treatment. It is therefore desirable to develop tumour-specific radiosensitising agents, which can increase tumour cell kill without increasing th...
Main Author: | Bittner, Martin-Immanuel |
---|---|
Other Authors: | Higgins, Geoffrey ; McKenna, Gillies |
Published: |
University of Oxford
2017
|
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.729068 |
Similar Items
-
Substrate Scope for Human Histone Lysine Acetyltransferase KAT8
by: Giordano Proietti, et al.
Published: (2021-01-01) -
A characterisation of the radiosensitising effects of gold nanoparticles
by: Taggart, L.
Published: (2014) -
Myst2/Kat7 histone acetyltransferase interaction proteomics reveals tumour-suppressor Niam as a novel binding partner in embryonic stem cells
by: Mercedes Pardo, et al.
Published: (2017-08-01) -
Synthesis of radiosensitisers targeted to DNA
by: Porssa, Manuchehr
Published: (1992) -
Novel hypoxia-selective prodrugs of radiosensitisers and chemosensitisers
by: Parveen, Ifat
Published: (2001)